HK ChopraSenior Consultant Cardiologist, Moolchand Medicity, New Delhi, India

• SECTION 1 CLINICAL SPECTRUMClinical Spectrum of CardiodiabetesRisk Factors for CardiodiabetesCardiodiabetes in ChildrenNew Genes for Type 2 Diabetes: Indian ScenarioStress and CardiodiabetesHypothyroidism and CardiodiabetesCardiodiabetes and Insulin Resistance in Obesity: Clinical RelevanceAnemia and Cardiodiabetes: Management StrategiesEndothelial Dysfunction in Atrial Fibrillation with Type 2 DMACS, Cardiodiabetes, and WomenCoronary Artery Disease in Diabetes: How Different is It from Nondiabetics?Cardiodiabetes and Heart Failure in the ElderlyPrognosis of Heart Failure in Diabetes: Newer PerspectivesCardiodiabetes Management and STEMI: PrognosticationSmall Vessel CAD in CardiodiabetesCardiodiabetes and Deep Venous ThrombosisPregnancy and CardiodiabetesCardiodiabetes and Autonomic InsufficiencyCardiodiabetes and Pulmonary Embolism: Is the Outcome Different?Cardiodiabetes and Cutaneous ManifestationsBenidipine for Hypertension in Chronic Kidney Disease with CardiodiabetesCardiorenal Diabetes: Triple JeopardyContrast-induced Acute Kidney InjuryCardiodiabetes and Hypertension: Double JeopardyCardiodiabetes and Obstructive Sleep ApneaCardiodiabetes and Mind-Heart ConnectionAortic Aneurysm Surgery in Cardiodiabetes: Is the Outcome Different?Cardiodiabetes and SyncopeCardiodiabetes and Sexual DysfunctionCardiodiabetes and Erectile DysfunctionEndothelial Cell Dysfunction in DM, HT and CAD, and Its Pathophysiology SECTION 2 DIAGNOSISCurrent Status of Diabetic CardiomyopathyInsulin Therapy and CardiodiabetesEcho-guided CRT in CardiodiabetesEchocardiography in DiabetesEcho/Doppler Assessment of Increased Left-sided Filling Pressures and Diastolic Heart Failure in Patients with Normal Systolic Function in Cardiodiabetes3D Echo and CardiodiabetesEmergency Echocardiography in CardiodiabetesDiabetic Cardiomyopathy: Studies on Global Longitudinal Strain in Asymptomatic Diabetic SubjectsStrain and Strain Rate Imaging in CardiodiabetesDobutamine Stress Echo for Coronary Artery Disease Evaluation in DiabeticsNoninvasive Cardiovascular Imaging for Risk Assessment in Asymptomatic Diabetic PatientsValue of Ankle–Brachial Index in CardiodiabetesComputed Tomography Evaluation of Abdominal Arterial Wall Calcification in Patients with Type 2 Diabetes MellitusCardiac MRI: A Promise, Hope or Hype in CardiodiabetesCT for CVD Evaluation in CardiodiabetesRecent Advances in Nuclear Cardiology and CardiodiabetesBlood Pressure Variability in CardiodiabetesCentral Aortic Blood Pressure Evaluation for Hypertension in CardiodiabeticsTelemedicine in Diabetes ManagementHbA1c: Clinical Relevance in CardiodiabetesEmerging Role of Cardiac Troponin in Cardiodiabetes SECTION 3 MANAGEMENT STRATEGIESRole of Yoga in CardiodiabetesMetabolic Effects of Antihypertensive DrugsPotential Role of Rosuvastatin in CardiodiabetesDiabetic Hypertriglyceridemia: Management StrategiesHigh-density Lipoprotein in CardiodiabetesGlucose-lowering Strategies and Cardiovascular OutcomesImproving CV Outcomes in Diabetes with New Antidiabetic Medications: A New Era has BegunPositioning of Once Weekly GLP–1- based Therapies for Whom and When?DPP-IV Inhibitors beyond Glycemic EfficacyInsulin Therapy and Cardiodiabetes in Critical CareLixisenatide: A Cardiodiabetes PerspectiveSGLT2-i Agents and Cardiovascular DiabetologySGLT2-i for the Reduction of Cardiovascular Events in High-risk Patients with Diabetes MellitusDiabetes and Heart Failure: New Data on the Role of SGLT 2 Inhibitors— A Change of Concept?Bisoprolol: Is It Superior in Cardiodiabetes?Bisoprolol: A Choice of Beta Blocker in Hypertension and ACS in CardiodiabetesBisoprolol in Heart Failure in CardiodiabetesNebivolol for Hypertension in CardiodiabetesARB for Hypertension in CardiodiabetesCKD and Hypertension: Is Benidipine Beneficial?Azilsartan: Promise and Power for Hypertension in CardiodiabetesBenidipine for Hypertension in CardiodiabetesAzilsartan: A Molecule of First Choice for Hypertension in CardiodiabetesSuperiority of Telmisartan: ARB, the First Choice in CardiodiabetesARNI in Heart Failure with Cardiodiabetes: The Way ForwardIndapamide versus Hydrochlorothiazide versus Chlorthalidone in CardiodiabetesPolypill for Cardiovascular Protection in DiabetesClopidogrel in Patients of Diabetes with Acute Coronary SyndromeAcute Coronary Syndrome in Cardiodiabetes: Is It Different?Newer Drugs in Heart Failure and Changes in Our Clinical ApproachRole of Oral Anticoagulants in Atrial Fibrillation with CardiodiabetesLow-molecular-weight Heparin in Acute Coronary Syndrome in CardiodiabetesMyocardial BridgingBenidipine for Hypertension in STEMI with CardiodiabetesThrombolytic Therapy of Choice in STEMI with CardiodiabetesTenecteplase and ST-elevation Myocardial Infarction with CardiodiabetesCardiodiabetes and StrokeHemorrhagic Stroke and CardiodiabetesPrognostication of STEMI in CardiodiabetesManagement of Hypertension in Diabetes: Special ConsiderationBenidipine: A New Calcium Channel Blocker for Management of Hypertension and Angina in CardiodiabetesAzilsartan for Hypertension Management in CardiodiabetesNeed for Registry of Cardiodiabetes in IndiaNonpharmacological Management of CardiodiabetesMaternal Diabetes Mellitus and Fetal Cardiac Malformations: Antenatal and Postnatal Management and OutcomeRole of Enhanced External Counterpulsation: Future Perspectives SECTION 4 NUTRACEUTICAL AND OBESITY CARERole of Vitamin D as Cardioprotection Strategy: Hope or Hype?Omega-3 Fatty Acids and Cardiovascular DiseaseRole of Red Yeast Rice and Phytosterols in DyslipidemiaMeal Replacement Therapy for Obesity Care in CardiodiabetesIdeal Edible Oil in CardiodiabetesCardiodiabetic Diet SECTION 5 ARRHYTHMIA MANAGEMENTCardiodiabetes and Heart Rate VariabilityNatural History of Atrial Fibrillation in Cardiodiabetes: Is it Different?Atrial Fibrillation: Management Strategies in CardiodiabeticsVentricular Tachycardia in Heart Failure with CardiodiabetesSudden Cardiac Death in Patients with Diabetes Mellitus: Prevalence, Predictors and Preventive StrategiesPrevention of Sudden Cardiac Death in CardiodiabetesPacing in CardiodiabetesRadiofrequency Ablation in Atrial Fibrillation in CardiodiabetesLA Appendage Closure for AF in Cardiodiabetes: Is the Outcome Different?AICD after Cardiac Arrest in Cardiodiabetes SECTION 6 INTERVENTIONCoronary Interventions in Cardiodiabetes PrognosticationPrimary PCI for STEMI in Cardiodiabetes: What is the Outcome?Optimizing Results of Percutaneous Coronary Intervention in Multivessel Disease with DiabetesSTEMI Management in Diabetes Mellitus: Is it Different?CTO with STEMI in Cardiodiabetes: Is the Outcome Different?Coronary Intervention in Venous Grafts in DiabetesCardiodiabetes and Peripheral Vascular InterventionsCardiodiabetes and VasculopathyCardiodiabetes and Carotid Artery InterventionsCoronary Revascularization in DiabeticsEndovascular Intervention in Stroke in Cardiodiabetes: New Frontiers SECTION 7 CARDIAC SURGERYCoronary Artery Bypass Grafting in CardiodiabetesCardiac Surgery and DiabetesECMO for Cardiodiabetes SECTION 8 REHABILITATIONCardiac Rehabilitation in CardiodiabetesPost-STEMI Intervention: Rehabilitation in CardiodiabetesRole of Nurses in a Structured Manner for Cardiac Rehabilitation in Cardiodiabetes SECTION 9 FUTURE DIRECTIONSType 2 Diabetes and Coronary Artery Bypass Grafting: Relation and Outcomes

HK ChopraSenior Consultant Cardiologist, Moolchand Medicity, New Delhi, India

• SECTION 1 CLINICAL SPECTRUMClinical Spectrum of CardiodiabetesRisk Factors for CardiodiabetesCardiodiabetes in ChildrenNew Genes for Type 2 Diabetes: Indian ScenarioStress and CardiodiabetesHypothyroidism and CardiodiabetesCardiodiabetes and Insulin Resistance in Obesity: Clinical RelevanceAnemia and Cardiodiabetes: Management StrategiesEndothelial Dysfunction in Atrial Fibrillation with Type 2 DMACS, Cardiodiabetes, and WomenCoronary Artery Disease in Diabetes: How Different is It from Nondiabetics?Cardiodiabetes and Heart Failure in the ElderlyPrognosis of Heart Failure in Diabetes: Newer PerspectivesCardiodiabetes Management and STEMI: PrognosticationSmall Vessel CAD in CardiodiabetesCardiodiabetes and Deep Venous ThrombosisPregnancy and CardiodiabetesCardiodiabetes and Autonomic InsufficiencyCardiodiabetes and Pulmonary Embolism: Is the Outcome Different?Cardiodiabetes and Cutaneous ManifestationsBenidipine for Hypertension in Chronic Kidney Disease with CardiodiabetesCardiorenal Diabetes: Triple JeopardyContrast-induced Acute Kidney InjuryCardiodiabetes and Hypertension: Double JeopardyCardiodiabetes and Obstructive Sleep ApneaCardiodiabetes and Mind-Heart ConnectionAortic Aneurysm Surgery in Cardiodiabetes: Is the Outcome Different?Cardiodiabetes and SyncopeCardiodiabetes and Sexual DysfunctionCardiodiabetes and Erectile DysfunctionEndothelial Cell Dysfunction in DM, HT and CAD, and Its Pathophysiology SECTION 2 DIAGNOSISCurrent Status of Diabetic CardiomyopathyInsulin Therapy and CardiodiabetesEcho-guided CRT in CardiodiabetesEchocardiography in DiabetesEcho/Doppler Assessment of Increased Left-sided Filling Pressures and Diastolic Heart Failure in Patients with Normal Systolic Function in Cardiodiabetes3D Echo and CardiodiabetesEmergency Echocardiography in CardiodiabetesDiabetic Cardiomyopathy: Studies on Global Longitudinal Strain in Asymptomatic Diabetic SubjectsStrain and Strain Rate Imaging in CardiodiabetesDobutamine Stress Echo for Coronary Artery Disease Evaluation in DiabeticsNoninvasive Cardiovascular Imaging for Risk Assessment in Asymptomatic Diabetic PatientsValue of Ankle–Brachial Index in CardiodiabetesComputed Tomography Evaluation of Abdominal Arterial Wall Calcification in Patients with Type 2 Diabetes MellitusCardiac MRI: A Promise, Hope or Hype in CardiodiabetesCT for CVD Evaluation in CardiodiabetesRecent Advances in Nuclear Cardiology and CardiodiabetesBlood Pressure Variability in CardiodiabetesCentral Aortic Blood Pressure Evaluation for Hypertension in CardiodiabeticsTelemedicine in Diabetes ManagementHbA1c: Clinical Relevance in CardiodiabetesEmerging Role of Cardiac Troponin in Cardiodiabetes SECTION 3 MANAGEMENT STRATEGIESRole of Yoga in CardiodiabetesMetabolic Effects of Antihypertensive DrugsPotential Role of Rosuvastatin in CardiodiabetesDiabetic Hypertriglyceridemia: Management StrategiesHigh-density Lipoprotein in CardiodiabetesGlucose-lowering Strategies and Cardiovascular OutcomesImproving CV Outcomes in Diabetes with New Antidiabetic Medications: A New Era has BegunPositioning of Once Weekly GLP–1- based Therapies for Whom and When?DPP-IV Inhibitors beyond Glycemic EfficacyInsulin Therapy and Cardiodiabetes in Critical CareLixisenatide: A Cardiodiabetes PerspectiveSGLT2-i Agents and Cardiovascular DiabetologySGLT2-i for the Reduction of Cardiovascular Events in High-risk Patients with Diabetes MellitusDiabetes and Heart Failure: New Data on the Role of SGLT 2 Inhibitors— A Change of Concept?Bisoprolol: Is It Superior in Cardiodiabetes?Bisoprolol: A Choice of Beta Blocker in Hypertension and ACS in CardiodiabetesBisoprolol in Heart Failure in CardiodiabetesNebivolol for Hypertension in CardiodiabetesARB for Hypertension in CardiodiabetesCKD and Hypertension: Is Benidipine Beneficial?Azilsartan: Promise and Power for Hypertension in CardiodiabetesBenidipine for Hypertension in CardiodiabetesAzilsartan: A Molecule of First Choice for Hypertension in CardiodiabetesSuperiority of Telmisartan: ARB, the First Choice in CardiodiabetesARNI in Heart Failure with Cardiodiabetes: The Way ForwardIndapamide versus Hydrochlorothiazide versus Chlorthalidone in CardiodiabetesPolypill for Cardiovascular Protection in DiabetesClopidogrel in Patients of Diabetes with Acute Coronary SyndromeAcute Coronary Syndrome in Cardiodiabetes: Is It Different?Newer Drugs in Heart Failure and Changes in Our Clinical ApproachRole of Oral Anticoagulants in Atrial Fibrillation with CardiodiabetesLow-molecular-weight Heparin in Acute Coronary Syndrome in CardiodiabetesMyocardial BridgingBenidipine for Hypertension in STEMI with CardiodiabetesThrombolytic Therapy of Choice in STEMI with CardiodiabetesTenecteplase and ST-elevation Myocardial Infarction with CardiodiabetesCardiodiabetes and StrokeHemorrhagic Stroke and CardiodiabetesPrognostication of STEMI in CardiodiabetesManagement of Hypertension in Diabetes: Special ConsiderationBenidipine: A New Calcium Channel Blocker for Management of Hypertension and Angina in CardiodiabetesAzilsartan for Hypertension Management in CardiodiabetesNeed for Registry of Cardiodiabetes in IndiaNonpharmacological Management of CardiodiabetesMaternal Diabetes Mellitus and Fetal Cardiac Malformations: Antenatal and Postnatal Management and OutcomeRole of Enhanced External Counterpulsation: Future Perspectives SECTION 4 NUTRACEUTICAL AND OBESITY CARERole of Vitamin D as Cardioprotection Strategy: Hope or Hype?Omega-3 Fatty Acids and Cardiovascular DiseaseRole of Red Yeast Rice and Phytosterols in DyslipidemiaMeal Replacement Therapy for Obesity Care in CardiodiabetesIdeal Edible Oil in CardiodiabetesCardiodiabetic Diet SECTION 5 ARRHYTHMIA MANAGEMENTCardiodiabetes and Heart Rate VariabilityNatural History of Atrial Fibrillation in Cardiodiabetes: Is it Different?Atrial Fibrillation: Management Strategies in CardiodiabeticsVentricular Tachycardia in Heart Failure with CardiodiabetesSudden Cardiac Death in Patients with Diabetes Mellitus: Prevalence, Predictors and Preventive StrategiesPrevention of Sudden Cardiac Death in CardiodiabetesPacing in CardiodiabetesRadiofrequency Ablation in Atrial Fibrillation in CardiodiabetesLA Appendage Closure for AF in Cardiodiabetes: Is the Outcome Different?AICD after Cardiac Arrest in Cardiodiabetes SECTION 6 INTERVENTIONCoronary Interventions in Cardiodiabetes PrognosticationPrimary PCI for STEMI in Cardiodiabetes: What is the Outcome?Optimizing Results of Percutaneous Coronary Intervention in Multivessel Disease with DiabetesSTEMI Management in Diabetes Mellitus: Is it Different?CTO with STEMI in Cardiodiabetes: Is the Outcome Different?Coronary Intervention in Venous Grafts in DiabetesCardiodiabetes and Peripheral Vascular InterventionsCardiodiabetes and VasculopathyCardiodiabetes and Carotid Artery InterventionsCoronary Revascularization in DiabeticsEndovascular Intervention in Stroke in Cardiodiabetes: New Frontiers SECTION 7 CARDIAC SURGERYCoronary Artery Bypass Grafting in CardiodiabetesCardiac Surgery and DiabetesECMO for Cardiodiabetes SECTION 8 REHABILITATIONCardiac Rehabilitation in CardiodiabetesPost-STEMI Intervention: Rehabilitation in CardiodiabetesRole of Nurses in a Structured Manner for Cardiac Rehabilitation in Cardiodiabetes SECTION 9 FUTURE DIRECTIONSType 2 Diabetes and Coronary Artery Bypass Grafting: Relation and Outcomes

HK ChopraSenior Consultant Cardiologist, Moolchand Medicity, New Delhi, India

• SECTION 1 CLINICAL SPECTRUMClinical Spectrum of CardiodiabetesRisk Factors for CardiodiabetesCardiodiabetes in ChildrenNew Genes for Type 2 Diabetes: Indian ScenarioStress and CardiodiabetesHypothyroidism and CardiodiabetesCardiodiabetes and Insulin Resistance in Obesity: Clinical RelevanceAnemia and Cardiodiabetes: Management StrategiesEndothelial Dysfunction in Atrial Fibrillation with Type 2 DMACS, Cardiodiabetes, and WomenCoronary Artery Disease in Diabetes: How Different is It from Nondiabetics?Cardiodiabetes and Heart Failure in the ElderlyPrognosis of Heart Failure in Diabetes: Newer PerspectivesCardiodiabetes Management and STEMI: PrognosticationSmall Vessel CAD in CardiodiabetesCardiodiabetes and Deep Venous ThrombosisPregnancy and CardiodiabetesCardiodiabetes and Autonomic InsufficiencyCardiodiabetes and Pulmonary Embolism: Is the Outcome Different?Cardiodiabetes and Cutaneous ManifestationsBenidipine for Hypertension in Chronic Kidney Disease with CardiodiabetesCardiorenal Diabetes: Triple JeopardyContrast-induced Acute Kidney InjuryCardiodiabetes and Hypertension: Double JeopardyCardiodiabetes and Obstructive Sleep ApneaCardiodiabetes and Mind-Heart ConnectionAortic Aneurysm Surgery in Cardiodiabetes: Is the Outcome Different?Cardiodiabetes and SyncopeCardiodiabetes and Sexual DysfunctionCardiodiabetes and Erectile DysfunctionEndothelial Cell Dysfunction in DM, HT and CAD, and Its Pathophysiology SECTION 2 DIAGNOSISCurrent Status of Diabetic CardiomyopathyInsulin Therapy and CardiodiabetesEcho-guided CRT in CardiodiabetesEchocardiography in DiabetesEcho/Doppler Assessment of Increased Left-sided Filling Pressures and Diastolic Heart Failure in Patients with Normal Systolic Function in Cardiodiabetes3D Echo and CardiodiabetesEmergency Echocardiography in CardiodiabetesDiabetic Cardiomyopathy: Studies on Global Longitudinal Strain in Asymptomatic Diabetic SubjectsStrain and Strain Rate Imaging in CardiodiabetesDobutamine Stress Echo for Coronary Artery Disease Evaluation in DiabeticsNoninvasive Cardiovascular Imaging for Risk Assessment in Asymptomatic Diabetic PatientsValue of Ankle–Brachial Index in CardiodiabetesComputed Tomography Evaluation of Abdominal Arterial Wall Calcification in Patients with Type 2 Diabetes MellitusCardiac MRI: A Promise, Hope or Hype in CardiodiabetesCT for CVD Evaluation in CardiodiabetesRecent Advances in Nuclear Cardiology and CardiodiabetesBlood Pressure Variability in CardiodiabetesCentral Aortic Blood Pressure Evaluation for Hypertension in CardiodiabeticsTelemedicine in Diabetes ManagementHbA1c: Clinical Relevance in CardiodiabetesEmerging Role of Cardiac Troponin in Cardiodiabetes SECTION 3 MANAGEMENT STRATEGIESRole of Yoga in CardiodiabetesMetabolic Effects of Antihypertensive DrugsPotential Role of Rosuvastatin in CardiodiabetesDiabetic Hypertriglyceridemia: Management StrategiesHigh-density Lipoprotein in CardiodiabetesGlucose-lowering Strategies and Cardiovascular OutcomesImproving CV Outcomes in Diabetes with New Antidiabetic Medications: A New Era has BegunPositioning of Once Weekly GLP–1- based Therapies for Whom and When?DPP-IV Inhibitors beyond Glycemic EfficacyInsulin Therapy and Cardiodiabetes in Critical CareLixisenatide: A Cardiodiabetes PerspectiveSGLT2-i Agents and Cardiovascular DiabetologySGLT2-i for the Reduction of Cardiovascular Events in High-risk Patients with Diabetes MellitusDiabetes and Heart Failure: New Data on the Role of SGLT 2 Inhibitors— A Change of Concept?Bisoprolol: Is It Superior in Cardiodiabetes?Bisoprolol: A Choice of Beta Blocker in Hypertension and ACS in CardiodiabetesBisoprolol in Heart Failure in CardiodiabetesNebivolol for Hypertension in CardiodiabetesARB for Hypertension in CardiodiabetesCKD and Hypertension: Is Benidipine Beneficial?Azilsartan: Promise and Power for Hypertension in CardiodiabetesBenidipine for Hypertension in CardiodiabetesAzilsartan: A Molecule of First Choice for Hypertension in CardiodiabetesSuperiority of Telmisartan: ARB, the First Choice in CardiodiabetesARNI in Heart Failure with Cardiodiabetes: The Way ForwardIndapamide versus Hydrochlorothiazide versus Chlorthalidone in CardiodiabetesPolypill for Cardiovascular Protection in DiabetesClopidogrel in Patients of Diabetes with Acute Coronary SyndromeAcute Coronary Syndrome in Cardiodiabetes: Is It Different?Newer Drugs in Heart Failure and Changes in Our Clinical ApproachRole of Oral Anticoagulants in Atrial Fibrillation with CardiodiabetesLow-molecular-weight Heparin in Acute Coronary Syndrome in CardiodiabetesMyocardial BridgingBenidipine for Hypertension in STEMI with CardiodiabetesThrombolytic Therapy of Choice in STEMI with CardiodiabetesTenecteplase and ST-elevation Myocardial Infarction with CardiodiabetesCardiodiabetes and StrokeHemorrhagic Stroke and CardiodiabetesPrognostication of STEMI in CardiodiabetesManagement of Hypertension in Diabetes: Special ConsiderationBenidipine: A New Calcium Channel Blocker for Management of Hypertension and Angina in CardiodiabetesAzilsartan for Hypertension Management in CardiodiabetesNeed for Registry of Cardiodiabetes in IndiaNonpharmacological Management of CardiodiabetesMaternal Diabetes Mellitus and Fetal Cardiac Malformations: Antenatal and Postnatal Management and OutcomeRole of Enhanced External Counterpulsation: Future Perspectives SECTION 4 NUTRACEUTICAL AND OBESITY CARERole of Vitamin D as Cardioprotection Strategy: Hope or Hype?Omega-3 Fatty Acids and Cardiovascular DiseaseRole of Red Yeast Rice and Phytosterols in DyslipidemiaMeal Replacement Therapy for Obesity Care in CardiodiabetesIdeal Edible Oil in CardiodiabetesCardiodiabetic Diet SECTION 5 ARRHYTHMIA MANAGEMENTCardiodiabetes and Heart Rate VariabilityNatural History of Atrial Fibrillation in Cardiodiabetes: Is it Different?Atrial Fibrillation: Management Strategies in CardiodiabeticsVentricular Tachycardia in Heart Failure with CardiodiabetesSudden Cardiac Death in Patients with Diabetes Mellitus: Prevalence, Predictors and Preventive StrategiesPrevention of Sudden Cardiac Death in CardiodiabetesPacing in CardiodiabetesRadiofrequency Ablation in Atrial Fibrillation in CardiodiabetesLA Appendage Closure for AF in Cardiodiabetes: Is the Outcome Different?AICD after Cardiac Arrest in Cardiodiabetes SECTION 6 INTERVENTIONCoronary Interventions in Cardiodiabetes PrognosticationPrimary PCI for STEMI in Cardiodiabetes: What is the Outcome?Optimizing Results of Percutaneous Coronary Intervention in Multivessel Disease with DiabetesSTEMI Management in Diabetes Mellitus: Is it Different?CTO with STEMI in Cardiodiabetes: Is the Outcome Different?Coronary Intervention in Venous Grafts in DiabetesCardiodiabetes and Peripheral Vascular InterventionsCardiodiabetes and VasculopathyCardiodiabetes and Carotid Artery InterventionsCoronary Revascularization in DiabeticsEndovascular Intervention in Stroke in Cardiodiabetes: New Frontiers SECTION 7 CARDIAC SURGERYCoronary Artery Bypass Grafting in CardiodiabetesCardiac Surgery and DiabetesECMO for Cardiodiabetes SECTION 8 REHABILITATIONCardiac Rehabilitation in CardiodiabetesPost-STEMI Intervention: Rehabilitation in CardiodiabetesRole of Nurses in a Structured Manner for Cardiac Rehabilitation in Cardiodiabetes SECTION 9 FUTURE DIRECTIONSType 2 Diabetes and Coronary Artery Bypass Grafting: Relation and Outcomes